Adaptin Bio (APTN) Return on Assets (2023 - 2026)

Adaptin Bio has disclosed Return on Assets across 4 years of filings, most recently posting 0.09% for Q1 2026.

• Quarterly Return on Assets fell 6.0% year-over-year to 0.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09% (down 6.0% YoY) and the FY2025 annual result came in at 0.12%, up 14.0% from the prior year.
• Return on Assets retreated to 0.09% in Q1 2026, from 0.07% in the prior quarter.
• Across five years, Return on Assets topped out at 0.02% in Q2 2025 and bottomed at 71.42% in Q3 2024.
• The 4-year median for Return on Assets is 0.17% (2024), against an average of 12.01%.
• Year-over-year, Return on Assets surged 7139 bps in 2025 and retreated 6 bps in 2026.
• Adaptin Bio's Return on Assets stood at 2.03% in 2023, then jumped by 87 bps to 0.26% in 2024, then surged by 75 bps to 0.07% in 2025, then sank by 33 bps to 0.09% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.09%, 0.07%, and 0.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.